Mitux E

Print
Barcode: 8935206007817
Description

MITUX E

COMPOSITION:

Acetylcysteine ....................................................... 100 mg

Excipients q.s....................................................... 1 sachet

(Orange-flavored powder, aspartame, betacarotene 20% DC, sunset yellow, sucrose, lactose).

DOSAGE FORM: Powder.

PRESENTATION: Box of 24 sachets x 1.5 g.

ACTIONS: Mitux E containing the active ingredient Acetylcysteine is a mucolytic agent which impacts on gel phase of viscous mucus by splitting of disulfur bonds in glycoproteins. The drug is used in the reduction of viscosity of pulmonary sputum to facilitate expectoration. After oral administration, acetylcysteine is rapidly absorbed from the gastrointestinal tract and achieves peak plasma concentrations within 0.5 - 1 hour. Due to the particular affinity to pulmonary tissues and bronchial secretions, acetylcysteine concentrations are effectively achieved after 3 hours taking the drug.

INDICATIONS:

Used as a mucolytic drug in the treatment of respiratory pathologies associated with viscous sputum e.g., bronchitis, tracheobronchitis, acute and chronic bronchopneumonia, rhinitis, laryngitis, sinusitis, secretory otitis media.

CONTRAINDICATIONS:

Hypersensitivity to acetylcysteine. Children aged less than 2 years.

A history of asthma (the risk of bronchospasm reaction to all acetylcysteine-containing drugs)

PRECAUTIONS:

Patients with bronchial asthma should be closely monitored during therapy; if bronchospasm occurs in patients with known hypertension, salbutamol or ipratropium inhaler should be given and treatment with acetylcysteine should be discontinued immediately.

Administration of acetylcysteine may liquefy bronchial secretions. At the same time, tracheal suction should be used.

PREGNANCY AND LACTATION:

Pregnancy: There are no controlled data on safety in pregnancy. Acetylcysteine is only taken if the potential benefits to the mother outweigh the risks to the fetus.

Lactation: There is no information on the excretion of acetylcysteine into human milk; however, acetylcysteine should be used with caution in nursing women.

EFFECTS ON ABILITY TO DRIVE AND USE MACHINES: No special cautions.

INTERACTIONS:

Concomitant administration of antitussive drugs and/or agents for drying mucous secretion and acetylcysteine is unreasonable.

ADVERSE EFFECTS:

Commonly: nausea, vomiting.

Uncommonly: drowsiness, headache, tinnitus, stomatitis, severe rhinorrhea, skin rash, urticaria.

Rarely: bronchopasm associated with systemic anaphylactic reaction, fever, tremble.

Inform your physician about any adverse effects occur during the treatment.

OVERDOSAGE:

Symptoms following overdosage with acetylcysteine have been similar to those of anaphylactoid reactions, but they may be more severe. Hypotension appears to be especially prominent. Other symptoms including respiratory insufficiency, hemolysis, disseminated intravascular coagulation, renal impairment have been reported. Fatality occurred in patient following overdosage with acetylcysteine while treating paracetamol poisoning. Treatment of overdosage depends on each symptom.

DOSAGE & ADMINISTRATION:

Children aged from 2 - 6 years: 2 sachets twice daily.

Or as directed by the physician.

Read the directions carefully before use.

Consult the physician for more information.

Shelf-life: 36 months from the manufacturing date.

Storage conditions: Store in a dry place, not exceeding 30oC, protect from light.

Specifications: Manufacturer's.

Reviews

There are yet no reviews for this product.